NCT00095979View on ClinicalTrials.gov

Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Endometrial AdenocarcinomaRecurrent Endometrial CarcinomaStage IV Endometrial Carcinoma
Interventions
DRUG

ixabepilone

Given IV

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors
collaborator

Gynecologic Oncology Group

NETWORK

lead

National Cancer Institute (NCI)

NIH

NCT00095979 - Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer | Biotech Hunter | Biotech Hunter